All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The FDA issued a draft guidance Wednesday on general clinical pharmacology considerations for neonatal drug studies as an adjunct to a 2014 draft guidance on pediatric studies.
